Fei Ma
Impact in
- Cancer Research top 1%
- Breast Cancer Treatment Studies
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- HER2/EGFR in Cancer Research
- Cancer Cells and Metastasis
- Cancer Immunotherapy and Biomarkers
- Cancer Treatment and Pharmacology
Papers in
- Oncology 179
- HER2/EGFR in Cancer Research 63
- Cancer Treatment and Pharmacology 56
- Cancer Cells and Metastasis 16
- Cancer Immunotherapy and Biomarkers 14
-
- Advanced Breast Cancer Therapies 37
- Lung Cancer Treatments and Mutations 28
- Co-authors
- Binghe Xu (116 shared papers)Ying Fan (97 shared papers)Pin Zhang (99 shared papers)Haili Qian (39 shared papers)Binghe Xu (67 shared papers)Yang Luo (74 shared papers)Jiayu Wang (66 shared papers)Ruigang Cai (59 shared papers)
- Journals
- Journal of Clinical Oncology (42 papers)The Breast (15 papers)Frontiers in Oncology (14 papers)Medicine (11 papers)Cancer Research (10 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Fei Ma
423 papers receiving 6.3k citations
Fei Ma's Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 1.4k
- Oncology 2.3k
- Pulmonary and Respiratory Medicine 1.0k
- Immunology 527
- Molecular Biology 1.7k
Countries citing papers authored by Fei Ma
This map shows the geographic impact of Fei Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fei Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fei Ma more than expected).
Fields of papers citing papers by Fei Ma
This network shows the impact of papers produced by Fei Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fei Ma. The network helps show where Fei Ma may publish in the future.
Co-authors
The 25 scholars most cited alongside Fei Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 454 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer Hit paper breakdown → | 2021 | 465 |
| 2 | 2019 | 253 | |
| 3 | 2014 | 194 | |
| 4 | 2017 | 171 | |
| 5 | 2018 | 161 | |
| 6 | 2014 | 122 | |
| 7 | 2019 | 85 | |
| 8 | 2021 | 82 | |
| 9 | 2016 | 77 | |
| 10 | 2022 | 75 | |
| 11 | 2012 | 75 | |
| 12 | 2015 | 66 | |
| 13 | 2019 | 64 | |
| 14 | 2016 | 63 | |
| 15 | 2019 | 62 | |
| 16 | 2014 | 60 | |
| 17 | 2013 | 59 | |
| 18 | 2018 | 58 | |
| 19 | 2021 | 53 | |
| 20 | 2020 | 52 |
About Fei Ma
Fei Ma is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 454 papers that have together received 6.4k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (63 papers), Cancer Treatment and Pharmacology (56 papers), Breast Cancer Treatment Studies (52 papers), Advanced Breast Cancer Therapies (37 papers), Lung Cancer Treatments and Mutations (28 papers), Cancer Genomics and Diagnostics (26 papers), Cancer Cells and Metastasis (16 papers) and Cancer Immunotherapy and Biomarkers (14 papers). The work is most often cited by research in Cancer Research (1.4k citations), Oncology (2.3k citations), Pulmonary and Respiratory Medicine (1.0k citations), Immunology (527 citations) and Molecular Biology (1.7k citations). Fei Ma has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Binghe Xu, Ying Fan, Pin Zhang, Haili Qian, Binghe Xu, Yang Luo, Jiayu Wang, Ruigang Cai, Zongbi Yi and Qiao Li. Their work appears in journals such as Journal of Clinical Oncology, The Breast, Frontiers in Oncology, Medicine and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.